Subakut sklerozan panensefalit (SSPE), kızamık enfeksiyonundan sonra ensefalit kliniği ile giden çoğunlukla ölümcül olabilen ilerleyici bir nörolojik hastalıktır.1960’lı yıllarda kızamık aşılamalarının başlaması ile hastalığın görülme sıklığı azalmıştır. Hastalar genellikle; davranış değişikliği, miyoklonik nöbetler, bilişsel yıkım ve içine kapanma gibi farklı semptomlarla başvurabilir. Hastalığın erken dönemlerinde çekilen elektroensefalografi bulguları tipik olsa da ilerlemiş dönemde spesifik değildir. Hastalığın kesin tedavisi yoktur, hastalığın seyrinde etkili olabilen immunomodülatör, karbamazepin gibi ilaçlar kullanılır.Davranış değişikliği, içe kapanıklık ve yoğun miyoklonik nöbetleri olan ve farklı dış merkezlerde epilepsi tanısı ile 3 yıldır takip edilen hastamız ile ülkemizde sıklığı azalmakla birlikte halen görülen SSPE hastalığına dikkat çekmek istedik.
Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disorder with encephalitis that develops after measles infection and can be fatal. The incidence has decreased substantially after the initial use of measles vaccine in the 1960s. Patients generally present with various symptoms such as behavioral disturbances, myoclonic seizures, mental retardation and becoming withdrawn. Electroencephalography findings are characteristic at the early stage of the disease, but nonspecific at later stages. There is no curative medical treatment for SSPE but drugs such as immunomodulators and carbamazepine are being used to prevent progression. We present a patient with SSPE who was diagnosed and medicated for epilepsy for 3 years although she was suffering from behavioral disturbances, depression and myoclonic seizures. We recommend clinicians to consider SSPE as it can still be seen in our country despite the decreasing incidence of measles infection
Other ID | JA43VB26ZP |
---|---|
Journal Section | Case Report |
Authors | |
Publication Date | December 1, 2016 |
Submission Date | December 1, 2016 |
Published in Issue | Year 2016 Volume: 10 Issue: 4 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.